Personal information

Activities

Employment (5)

Regeneron Pharmaceuticals Inc: Tarrytown, NY, US

2020-02 to present | Senior Clinical Pharmacologist (Drug Safety and Pharmacometrics)
Employment
Source: Self-asserted source
Samit Ganguly

Eshelman School of Pharmacy, University of North Carolina at Chapel Hill: Chapel Hill, NC, US

2018-07 to present | Postdoctoral Research Associate (Division of Pharmacotherapy and Experimental Therapeutics)
Employment
Source: Self-asserted source
Samit Ganguly

Saint Jude Children's Research Hospital: Memphis, TN, US

2013-01 to present | Graduate Research Assistant (Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Samit Ganguly

AstraZeneca (India): Bengaluru, Karnataka, IN

2007-07 to 2012-07 | Assistant Research Scientist II (Drug Metabolism and Pharmacokinetics)
Employment
Source: Self-asserted source
Samit Ganguly

Wockhardt Research Centre: Aurangabad, Maharashtra, IN

2007-01 to 2007-05 | Project Trainee (DMPK and Safety Pharmacology)
Employment
Source: Self-asserted source
Samit Ganguly

Education and qualifications (3)

University of Tennessee Health Science Center: Memphis, TN, US

2012-08-01 to 2018-06-30 | Ph. D. (Biomedical Sciences)
Education
Source: Self-asserted source
Samit Ganguly

Birla Institute of Technology and Science: Pilani, Rajasthan, IN

2005-06 to 2007-06 | M. Pharm (Pharmaceutical Sciences)
Education
Source: Self-asserted source
Samit Ganguly

Jadavpur University: Kolkata, West Bengal, IN

2001-06 to 2005-06 | B. Pharm (Pharmaceutical Sciences)
Education
Source: Self-asserted source
Samit Ganguly

Works (16)

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2022-07-02 | Journal article
Contributors: Isa F; Forleo-Neto E; Jonathan Aaron Meyer; Zheng W; Rasmussen S; Armas D; Oshita M; Brinson C; Folkerth S; Faria L et al.
Source: Self-asserted source
Samit Ganguly

External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data.

Frontiers in pharmacology
2022-03-17 | Journal article
Contributors: Karatza E; Ganguly S; Hornik CD; Muller WJ; Al-Uzri A; James L; Balevic SJ; Gonzalez D
Source: Self-asserted source
Samit Ganguly

REGEN-COV<sup>®</sup> antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantification.

Bioanalysis
2021-11-08 | Journal article
Contributors: Irvin SC; Ganguly S; Weiss R; Elango C; Zhong X; Mao Y; Yan H; Li N; Sumner G; Turner KC et al.
Source: Self-asserted source
Samit Ganguly

Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling.

Clinical pharmacokinetics
2021-10-07 | Journal article
Contributors: Gerhart JG; Carreño FO; Edginton AN; Sinha J; Perrin EM; Karan R Kumar; Rikhi A; Hornik CP; Harris V; Ganguly S et al.
Source: Self-asserted source
Samit Ganguly

Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.

PloS one
2021-07-13 | Journal article
Contributors: Ganguly S; Finkelstein D; Timothy Shaw; Michalek RD; Zorn KM; Ekins S; Yasuda K; Fukuda Y; Schuetz JD; Mukherjee K et al.
Source: Self-asserted source
Samit Ganguly

Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants.

Clinical pharmacokinetics
2021-06-22 | Journal article | Author
Contributors: Samit Ganguly; Edginton AN; Jacqueline Gerhart; Michael Cohen-Wolkowiez; Greenberg RG; Daniel Gonzalez; Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee
Source: Self-asserted source
Samit Ganguly

Role of Vitamins A and D in BCR-ABL Arf-/- Acute Lymphoblastic Leukemia.

Scientific reports
2020-02-11 | Journal article
Source: Self-asserted source
Samit Ganguly

Ketamine pharmacokinetics and pharmacodynamics are altered by P-glycoprotein and breast cancer resistance protein efflux transporters in mice

Drug Metabolism and Disposition
2018 | Journal article
EID:

2-s2.0-85048410620

Contributors: Ganguly, S.; Panetta, J.C.; Roberts, J.K.; Schuetz, E.G.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

Pheophorbide A: Fluorescent bcrp substrate to measure oral drug-drug interactions in real-time In Vivo

Drug Metabolism and Disposition
2018 | Journal article
EID:

2-s2.0-85055074936

Contributors: Yasuda, K.; Ganguly, S.; Schuetz, E.G.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

In vivo imaging of human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice

Drug Metabolism and Disposition
2015 | Journal article
EID:

2-s2.0-84946201183

Contributors: Yasuda, K.; Cline, C.; Lin, Y.S.; Scheib, R.; Ganguly, S.; Thirumaran, R.K.; Chaudhry, A.; Kim, R.B.; Schuetz, E.G.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against mycobacterium tuberculosis

Journal of Medicinal Chemistry
2014 | Journal article
EID:

2-s2.0-84902499633

Contributors: Hameed P, S.; Patil, V.; Solapure, S.; Sharma, U.; Madhavapeddi, P.; Raichurkar, A.; Chinnapattu, M.; Manjrekar, P.; Shanbhag, G.; Puttur, J. et al.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy

Bioorganic and Medicinal Chemistry Letters
2014 | Journal article
EID:

2-s2.0-84893648853

Contributors: Kale, R.R.; Kale, M.G.; Waterson, D.; Raichurkar, A.; Hameed, S.P.; Manjunatha, M.R.; Kishore Reddy, B.K.; Malolanarasimhan, K.; Shinde, V.; Koushik, K. et al.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

Effect of repeated dosing on rifampin exposure in BALB/c mice

European Journal of Pharmaceutical Sciences
2013 | Journal article
EID:

2-s2.0-84874932404

Contributors: Hosagrahara, V.; Reddy, J.; Ganguly, S.; Panduga, V.; Ahuja, V.; Parab, M.; Giridhar, J.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy
2013 | Journal article
EID:

2-s2.0-84877867986

Contributors: Solapure, S.; Dinesh, N.; Shandil, R.; Ramachandran, V.; Sharma, S.; Bhattacharjee, D.; Ganguly, S.; Reddy, J.; Ahuja, V.; Panduga, V. et al.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA gyrase B

Journal of Medicinal Chemistry
2013 | Journal article
EID:

2-s2.0-84887899444

Contributors: Kale, M.G.; Raichurkar, A.; Shahul Hameed, P.; Waterson, D.; McKinney, D.; Manjunatha, M.R.; Kranthi, U.; Koushik, K.; Jena, L.K.; Shinde, V. et al.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model

Antimicrobial Agents and Chemotherapy
2012 | Journal article
EID:

2-s2.0-84861120913

Contributors: Balasubramanian, V.; Solapure, S.; Gaonkar, S.; Mahesh Kumar, K.N.; Shandil, R.K.; Deshpande, A.; Kumar, N.; Vishwas, K.G.; Panduga, V.; Reddy, J. et al.
Source: Self-asserted source
Samit Ganguly via Scopus - Elsevier

Peer review (32 reviews for 7 publications/grants)

Review activity for Antibodies. (2)
Review activity for Drug metabolism and disposition. (2)
Review activity for Journal of pharmaceutical sciences. (3)
Review activity for Molecules. (1)
Review activity for Pharmaceuticals. (1)
Review activity for Pharmaceutics. (17)
Review activity for The journal of pharmacology and experimental therapeutics. (6)